Midostaurin in Advanced Systemic Mastocytosis
Chandesris, Marie-Olivia, Damaj, Gandhi, Canioni, Danielle, Brouzes, Chantal, Lhermitte, Ludovic, Hanssens, Katia, Frenzel, Laurent, Cherquaoui, Zoubair, Durieu, Isabelle, Durupt, Stéphane, Gyan, Emmanuel, Beyne-Rauzy, Odille, Launay, David, Faure, Cyril, Hamidou, Mohamed, Besnard, Sophie, Diouf, Momar, Schiffmann, Aurélie, Niault, Mathilde, Jeandel, Pierre-Yves, Ranta, Dana, Gressin, Remi, Chantepie, Sylvain, Barete, Stéphane, Dubreuil, Patrice, Bourget, Philippe, Lortholary, Olivier, Hermine, Olivier
Published in The New England journal of medicine (30.06.2016)
Published in The New England journal of medicine (30.06.2016)
Get full text
Journal Article
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years
Gyan, Emmanuel, Foussard, Charles, Bertrand, Philippe, Michenet, Patrick, Le Gouill, Steven, Berthou, Christian, Maisonneuve, Hervé, Delwail, Vincent, Gressin, Rémi, Quittet, Philippe, Vilque, Jean-Pierre, Desablens, Bernard, Jaubert, Jérôme, Ramée, Jean-François, Arakelyan, Nina, Thyss, Antoine, Moluçon-Chabrot, Cécile, Delépine, Roselyne, Milpied, Noël, Colombat, Philippe, Deconinck, Eric
Published in Blood (29.01.2009)
Published in Blood (29.01.2009)
Get full text
Journal Article
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS
Houot, R., Le Gouill, S., Ojeda Uribe, M., Mounier, C., Courby, S., Dartigeas, C., Bouabdallah, K., Alexis Vigier, M., Moles, M.P., Tournilhac, O., Arakelyan, N., Rodon, P., El Yamani, A., Sutton, L., Fornecker, L., Assouline, D., Harousseau, J.L., Maisonneuve, H., Caulet-Maugendre, S., Gressin, R.
Published in Annals of oncology (01.06.2012)
Published in Annals of oncology (01.06.2012)
Get full text
Journal Article
Rituximab Given after High Dose Therapy and Autologous Stem Cell Transplantation Induces Durable Clearance of Minimal Residual Disease in about Half of the Patients with Follicular Non Hodgkin's Lymphoma : 36 Months Results of a Multicenter Open Label Phase II Trial (M39012 Trial)
Morschhauser, Franck, Recher, Christian, Milpied, Noel, Gressin, Remi, Salles, Gilles, Brice, Pauline, Vey, Norbert, Haioun, Corinne, Colombat, Philippe, Bourhis, Jean-Henri, Rossi, Jean-Francois, Berriot-Varoqueaux, Nathalie, Bergougnoux, Loic, Bosly, Andre, Delsol, Georges, Attal, Michel
Published in Blood (16.11.2004)
Published in Blood (16.11.2004)
Get full text
Journal Article